|
Nov 26, 2012, 11.53 AM IST
GlaxoSmithKline Plc plans to raise its stake in its Indian consumer products arm GlaxoSmithKline Consumer Healthcare Ltd to 75% from 43.16% through an open offer, the manager to the offer said on Monday.
GlaxoSmithKline along with its units will buy up to 13.39 million shares, or 31.84% in GlaxoSmithKline Consumer Healthcare, at Rs.3,900 per share, said HSBC Securities Ltd, the manager to the offer, in a statement. Also Read: GlaxoSmithKline Pharma Q3 net up 4.44% at Rs 152.34 cr As per Indian regulations, promoters of stock exchange-listed companies can hold up to a maximum of 75% stake. If the promoter shareholding rises beyond 75%, then the company has to be de-listed from the bourses. GlaxoSmithKline Pharmaceuticals was quoting at Rs 2,085, up Rs 86.55, or 4.33%. GlaxoSmithKline Consumer Healthcare was quoting at Rs 3,651.80, up Rs 608.60, or 20%. It has touched a 52-week high of Rs 3,651.80.
Set email alert for |
 From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'  The latest earning numbers FIRST on CNBC-TV18
News Videos
|
